We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

IQVIA Holdings Inc (IQV) USD0.01

Sell:$228.02 Buy:$228.18 Change: $0.92 (0.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Change: $0.92 (0.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Change: $0.92 (0.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.

Contact details

United States
+1 (919) 9982000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$41.25 billion
Shares in issue:
181.50 million
Life Sciences Tools & Services
New York Stock Exchange
United States
US dollar

Key personnel

  • Ari Bousbib
    Chairman of the Board, Chief Executive Officer
  • Ronald Bruehlman
    Chief Financial Officer, Executive Vice President
  • Kevin Knightly
    President - Corporate Strategy and Enterprise Networks
  • Walter Staub
    President - Research and Development Solutions
  • Eric Sherbet
    Executive Vice President, General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.